FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322216823> ?p ?o ?g. }

• W4322216823 endingPage "2502" @default.
• W4322216823 startingPage "2493" @default.
• W4322216823 abstract "Since the introduction of BRAF(/MEK) inhibition and immune checkpoint inhibition (ICI), the prognosis of advanced melanoma has greatly improved. Melanoma is known for its remarkably long time to first distant recurrence (TFDR), which can be decades in some patients and is partly attributed to immune-surveillance. We investigated the relationship between TFDR and patient outcomes after systemic treatment for advanced melanoma. We selected patients undergoing first-line systemic therapy for advanced melanoma from the nationwide Dutch Melanoma Treatment Registry. The association between TFDR and progression-free survival (PFS) and overall survival (OS) was assessed by Cox proportional hazard regression models. The TFDR was modeled categorically, linearly, and flexibly using restricted cubic splines. Patients received anti-PD-1-based treatment (n = 1844) or BRAF(/MEK) inhibition (n = 1618). For ICI-treated patients with a TFDR <2 years, median OS was 25.0 months, compared to 37.3 months for a TFDR >5 years (P = .014). Patients treated with BRAF(/MEK) inhibition with a longer TFDR also had a significantly longer median OS (8.6 months for TFDR <2 years compared to 11.1 months for >5 years, P = .004). The hazard of dying rapidly decreased with increasing TFDR until approximately 5 years (HR 0.87), after which the hazard of dying further decreased with increasing TFDR, but less strongly (HR 0.82 for a TFDR of 10 years and HR 0.79 for a TFDR of 15 years). Results were similar when stratifying for type of treatment. Advanced melanoma patients with longer TFDR have a prolonged PFS and OS, irrespective of being treated with first-line ICI or targeted therapy." @default.
• W4322216823 created "2023-02-27" @default.
• W4322216823 creator A5000559108 @default.
• W4322216823 creator A5007269008 @default.
• W4322216823 creator A5013384569 @default.
• W4322216823 creator A5017136846 @default.
• W4322216823 creator A5018011096 @default.
• W4322216823 creator A5018405051 @default.
• W4322216823 creator A5019881060 @default.
• W4322216823 creator A5024976681 @default.
• W4322216823 creator A5028034089 @default.
• W4322216823 creator A5030418421 @default.
• W4322216823 creator A5031300611 @default.
• W4322216823 creator A5031506026 @default.
• W4322216823 creator A5034061890 @default.
• W4322216823 creator A5043575344 @default.
• W4322216823 creator A5049092680 @default.
• W4322216823 creator A5053071529 @default.
• W4322216823 creator A5057991836 @default.
• W4322216823 creator A5058399030 @default.
• W4322216823 creator A5066417924 @default.
• W4322216823 creator A5076661327 @default.
• W4322216823 creator A5077018603 @default.
• W4322216823 creator A5081011064 @default.
• W4322216823 creator A5087475694 @default.
• W4322216823 creator A5088390068 @default.
• W4322216823 creator A5089729046 @default.
• W4322216823 date "2023-03-04" @default.
• W4322216823 modified "2023-10-01" @default.
• W4322216823 title "Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma" @default.
• W4322216823 cites W1919811975 @default.
• W4322216823 cites W2005612119 @default.
• W4322216823 cites W2006986876 @default.
• W4322216823 cites W2077344825 @default.
• W4322216823 cites W2127858747 @default.
• W4322216823 cites W2156405206 @default.
• W4322216823 cites W2506992739 @default.
• W4322216823 cites W2561799613 @default.
• W4322216823 cites W2761633778 @default.
• W4322216823 cites W2926370308 @default.
• W4322216823 cites W2943253226 @default.
• W4322216823 cites W3113787349 @default.
• W4322216823 cites W3128646645 @default.
• W4322216823 cites W3146983201 @default.
• W4322216823 cites W4226258201 @default.
• W4322216823 doi "https://doi.org/10.1002/ijc.34479" @default.
• W4322216823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36843274" @default.
• W4322216823 hasPublicationYear "2023" @default.
• W4322216823 type Work @default.
• W4322216823 citedByCount "0" @default.
• W4322216823 crossrefType "journal-article" @default.
• W4322216823 hasAuthorship W4322216823A5000559108 @default.
• W4322216823 hasAuthorship W4322216823A5007269008 @default.
• W4322216823 hasAuthorship W4322216823A5013384569 @default.
• W4322216823 hasAuthorship W4322216823A5017136846 @default.
• W4322216823 hasAuthorship W4322216823A5018011096 @default.
• W4322216823 hasAuthorship W4322216823A5018405051 @default.
• W4322216823 hasAuthorship W4322216823A5019881060 @default.
• W4322216823 hasAuthorship W4322216823A5024976681 @default.
• W4322216823 hasAuthorship W4322216823A5028034089 @default.
• W4322216823 hasAuthorship W4322216823A5030418421 @default.
• W4322216823 hasAuthorship W4322216823A5031300611 @default.
• W4322216823 hasAuthorship W4322216823A5031506026 @default.
• W4322216823 hasAuthorship W4322216823A5034061890 @default.
• W4322216823 hasAuthorship W4322216823A5043575344 @default.
• W4322216823 hasAuthorship W4322216823A5049092680 @default.
• W4322216823 hasAuthorship W4322216823A5053071529 @default.
• W4322216823 hasAuthorship W4322216823A5057991836 @default.
• W4322216823 hasAuthorship W4322216823A5058399030 @default.
• W4322216823 hasAuthorship W4322216823A5066417924 @default.
• W4322216823 hasAuthorship W4322216823A5076661327 @default.
• W4322216823 hasAuthorship W4322216823A5077018603 @default.
• W4322216823 hasAuthorship W4322216823A5081011064 @default.
• W4322216823 hasAuthorship W4322216823A5087475694 @default.
• W4322216823 hasAuthorship W4322216823A5088390068 @default.
• W4322216823 hasAuthorship W4322216823A5089729046 @default.
• W4322216823 hasBestOaLocation W43222168231 @default.
• W4322216823 hasConcept C10515644 @default.
• W4322216823 hasConcept C126322002 @default.
• W4322216823 hasConcept C143998085 @default.
• W4322216823 hasConcept C207103383 @default.
• W4322216823 hasConcept C2777658100 @default.
• W4322216823 hasConcept C44249647 @default.
• W4322216823 hasConcept C502942594 @default.
• W4322216823 hasConcept C50382708 @default.
• W4322216823 hasConcept C71924100 @default.
• W4322216823 hasConceptScore W4322216823C10515644 @default.
• W4322216823 hasConceptScore W4322216823C126322002 @default.
• W4322216823 hasConceptScore W4322216823C143998085 @default.
• W4322216823 hasConceptScore W4322216823C207103383 @default.
• W4322216823 hasConceptScore W4322216823C2777658100 @default.
• W4322216823 hasConceptScore W4322216823C44249647 @default.
• W4322216823 hasConceptScore W4322216823C502942594 @default.
• W4322216823 hasConceptScore W4322216823C50382708 @default.
• W4322216823 hasConceptScore W4322216823C71924100 @default.
• W4322216823 hasIssue "12" @default.
• W4322216823 hasLocation W43222168231 @default.
• W4322216823 hasLocation W43222168232 @default.

• next